|
Company:
|
AXOGEN, INC. (AXGN)
|
|
Form Type:
|
8-K
|
|
Filing Date:
|
7/11/2013
|
|
CIK:
|
0000805928
|
|
Address:
|
13631 PROGRESS BLVD.
SUITE 400
|
|
City, State, Zip:
|
ALACHUA, Florida 32615
|
|
Telephone:
|
(386) 462-6817
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$40.25
|
Change:
-0.40 (-0.98%)
|
Trade Time:
Apr 19
|
Market Cap:
$1.39B
|
|
|
|
|
|
|
Description of Business
|
|
We are a global leader in developing and marketing surgical solutions for
peripheral nerves. We provide products and education to improve surgical
treatment algorithms for peripheral nerve damage or discontinuity. Our portfolio
of products includes Avance® Nerve Graft, an off-the-shelf processed human nerve
allograft for bridging severed peripheral nerves without the comorbidities
associated with a second surgical site, AxoGuard® Nerve Connector, a porcine
submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of
severed peripheral nerves, AxoGuard® Nerve Protector, a porcine submucosa ECM
product used to wrap and protect damaged peripheral nerves and reinforce the
nerve reconstruction while preventing soft tissue attachments and Avive® Soft
Tissue Membrane, a minimally processed human umbilical cord membrane that may be
used as a resorbable soft tissue covering to separate tissues and modulate
inflammation in the surgical bed.
|
|
|
|